For: | Sakin A, Arici S, Secmeler S, Can O, Geredeli C, Yasar N, Demir C, Demir OG, Cihan S. Prognostic significance of primary tumor localization in stage II and III colon cancer. World J Gastrointest Oncol 2018; 10(11): 410-420 [PMID: 30487952 DOI: 10.4251/wjgo.v10.i11.410] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v10/i11/410.htm |
Number | Citing Articles |
1 |
Shah Zeb Khan, Ismat Fatima. Early postoperative recurrences for colon cancer: Results from a Pakistani rural cohort. Journal of Taibah University Medical Sciences 2020; 15(3): 232 doi: 10.1016/j.jtumed.2020.03.004
|
2 |
Hoang Minh Cuong, Vu Hong Thang, Bui-Thi Thu Huong, Nguyen Thuan Loi, Nguyen Minh Duc. KRAS mutations and their associations with clinicopathological features and survival in Vietnamese non‑polyp colon cancer patients. Molecular and Clinical Oncology 2023; 19(2) doi: 10.3892/mco.2023.2659
|
3 |
Mert Erciyestepe, Oğuzhan Selvi, Gülhan Dinç, Ahmet Emin Öztürk, Okan Aydın, Şermin Dinç Sonuşen, Tuğçe Kübra Güneş, Tugay Avcı, Sezai Vatansever, Emir Çelik, Muhammed Mustafa Atcı. Factors Affecting Recurrence and Survival in Stage IIA Colon Cancer Patients. Oncology 2024; 102(12): 1009 doi: 10.1159/000540334
|
4 |
Peter Radeczky, Judit Moldvay, Janos Fillinger, Beata Szeitz, Bence Ferencz, Kristiina Boettiger, Melinda Rezeli, Krisztina Bogos, Ferenc Renyi-Vamos, Konrad Hoetzenecker, Balazs Hegedus, Zsolt Megyesfalvi, Balazs Dome. Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.1609926
|
5 |
He Jiang, Baoguang Hu, Qi Dong. “Hands” teaching method in colorectal anatomy: A model can be used in teaching and communication. Asian Journal of Surgery 2021; 44(7): 982 doi: 10.1016/j.asjsur.2021.04.018
|
6 |
Serdar Arici, Jamshid Hamdard, Abdullah Sakin, Selma Sengiz Erhan, Muhammed Mustafa Atci, Ruhper Cekin, Burcu Saka, Emin Köse, Tuba Saydam, Caglayan Geredeli, Sener Cihan, Ahmet Bilici. The conversion of RAS status in metastatic colorectal cancer patients after first‐line biological agent treatment. Colorectal Disease 2021; 23(1): 206 doi: 10.1111/codi.15389
|